Alteration in the levels of 1,25-(OH)2D3 and corticosterone found in experimental diabetes reduces nerve growth factor (NGF) gene expression in vitro
- 31 December 1992
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 50 (23) , 1769-1772
- https://doi.org/10.1016/0024-3205(92)90060-3
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The steroid hormone of sunlight soltriol (vitamin D) as a seasonal regulator of biological activities and photoperiodic rhythmsThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- Antagonistic effects of dexamethasone and 1,25-dihydroxyvitamin D3 on the synthesis of nerve growth factorMolecular and Cellular Endocrinology, 1991
- Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathyJournal of Neuroscience Research, 1990
- Levels of nerve growth factor secreted by rat primary fibroblasts and iris transplants are influenced by serum and glucocorticoidsDevelopmental Brain Research, 1989
- Diabetic neuropathyAnnals of Neurology, 1984
- The Duodenal lμ,25-Dihydroxyvitamin D3Receptor in Rats with Experimentally Induced Diabetes*Endocrinology, 1983
- Vitamin D metabolism in insulin-dependent diabetes mellitusMetabolic Bone Disease and Related Research, 1982
- Diabetes Mellitus and Its Degenerative Complications: A Prospective Study of 4,400 Patients Observed Between 1947 and 1973Diabetes Care, 1978
- Diabetes Mellitus and Its Degenerative Complications: A Prospective Study of 4,400 Patients Observed Between 1947 and 1973Diabetes Care, 1978
- Experimental Diabetes Reduces Circulating 1,25-Dihydroxyvitamin D in the RatScience, 1977